Advances in Precision Medicine Oncology
Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such top...
Gorde:
| Formatua: | Online |
|---|---|
| Hizkuntza: | ingelesa |
| Argitaratua: |
IntechOpen
2023
|
| Gaiak: | |
| Sarrera elektronikoa: | ONIX_20231201_9781839688683_2189 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
| _version_ | 1869517627798323200 |
|---|---|
| collection | Directory of Open Access Books |
| description | Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin’s drug resistance and critical side effects. |
| format | Online |
| id | doab-20.500.12854ir-131078 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1310782024-03-31T22:45:52Z Advances in Precision Medicine Oncology Arnouk, Hilal Abdul Rasool Hassan, Bassam immunotherapy, doxorubicin, cancer immunotherapy, cancer, optimization, nanoparticles thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin’s drug resistance and critical side effects. 2023-12-01T18:49:46Z 2023-12-01T18:49:46Z 2021 book ONIX_20231201_9781839688683_2189 9781839688683 9781839688676 9781839688690 https://directory.doabooks.org/handle/20.500.12854/131078 eng image/jpeg n/a https://www.intechopen.com/books/10321 https://mts.intechopen.com/storage/books/10321/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.91507 10.5772/intechopen.91507 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781839688683 9781839688676 9781839688690 IntechOpen 260 open access |
| spellingShingle | immunotherapy, doxorubicin, cancer immunotherapy, cancer, optimization, nanoparticles thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Advances in Precision Medicine Oncology |
| title | Advances in Precision Medicine Oncology |
| title_full | Advances in Precision Medicine Oncology |
| title_fullStr | Advances in Precision Medicine Oncology |
| title_full_unstemmed | Advances in Precision Medicine Oncology |
| title_short | Advances in Precision Medicine Oncology |
| title_sort | advances in precision medicine oncology |
| topic | immunotherapy, doxorubicin, cancer immunotherapy, cancer, optimization, nanoparticles thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | immunotherapy, doxorubicin, cancer immunotherapy, cancer, optimization, nanoparticles thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20231201_9781839688683_2189 |